mySugr App | Accu-Chek®
User Guide for mySugr models including: Blood Glucose Meter App, Blood Glucose Meter, App
mySugr App hcp | Accu-Chek
Diabetes data, connected for results. Your patients are unique. Their diabetes therapy should be too. Use of the mySugr app connected with an Accu‑Chek Guide blood glucose meter supports your patients with type 2 diabetes
File Info : application/pdf, 1 Pages, 3.63MB
DocumentDocumentDiabetes data, connected for results. Your patients are unique. Their diabetes therapy should be too. Use of the mySugr® app connected with an AccuChek® Guide blood glucose meter supports your patients with type 2 diabetes and improves their glycemic management.1 Real world data, for real world results. Retrospective analysis of real world data shows a significant improvement in diabetes management in patients with type 2 diabetes using a blood glucose meter connected to the mySugr app. 3,274 patients with T1DM and T2DM* 597 are from Canada (29.31% T1D & 70.69% T2D) *T1DM = type 1 diabetes, T2DM = type 2 diabetes 9 countries in Europe & Canada2 Enrollment criteria Patients with T1DM or T2DM were enrolled between March 2013 and May 2022. They were highly engaged in their diabetes selfcare, logging two or more glucose test results per day during 14 days in a period of 30 days. Retrospective analysis Impact on estimated HbA1c3 (eHbA1c) and percentage of tests in range were calculated after 4 months of connecting the blood glucose meter to the mySugr app. eHbA1c (difference pre/post mySugr use in %) % of Tests (%) Reduction of estimated HbA1c T2DM: n=1,865 (56.96%) 0.2 0.0 -0.2 -0.4 -0.6 -0.8 -1.0 -1-0 0-1 1-2 2-3 3-4 Time since mySugr app-meter connectivity (in months) T2DM p<0.001 Improved glycemic control A statistically significant reduction of 0.35% of eHbA1c was observed after 4 months of blood glucose meter and mySugr app connectivity in patients with T2DM. There was also a significant improvement in those with an initial eHbA1c >7.5% (0.58% reduction), and even higher in those with initial eHbA1c above 9% (1.76%). Blood glucose tests in T2DM patients 100 9.3 7.3 6.7 6.6 6.4 80 19.8 17.5 16.9 17 16.5 60 40 69.1 73.5 74.6 74.6 75.2 20 1.3 1.3 1.3 1.3 1.3 0 -1-0 0-1 1-2 2-3 3-4 Very High |> 13.9 mmol/L High | 10.1 13.9 mmol/L In Range | 3.9 10.0 mmol/l Low | 3.1 3.8 mmol/l Very Low | < 3.0 mmol/l p<0.001 Time since mySugr app-meter connectivity (in months) Increased percentage of tests in range The percentage of blood glucose tests in range by T2DM patients increased by 6.13 percentage points with mySugr app connectivity, which was already observed after one month of apptometer connectivity. 1. Mayor R, et al. Real World Data Analysis shows a Significant Improvement on Glycemic Management When Using a Blood Glucose Meter Connected with a Mobile Health Application in People with Diabetes. 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Berlin, 2023. Poster nº 616. 2. Spain, Portugal, Canada, Netherlands, Belgium, Denmark, Sweden, Norway, Finland and UK. 3. Nathan DM., Kuenen J., Borg R., Zheng H., Schoenfeld D., Heine RJ. A1cDerived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008 Aug;31(8):14738. 4. As of June 19, 2023. 5. Average app rating in App Store and Google Play Store worldwide, 20230301, 20230531. MYSUGR and ACCU-CHEK GUIDE are registered trademarks of Roche. All other trademarks and product names are the property of their respective owners. © 2023 Roche Diabetes Care. CA-1730 4 5 Visit mySugrApp.ca